“Monoclonal antibody against CGRP (TEV-48125) for preventive treatment of episodic cluster headache: a phase II randomized clinical trial protocol” (2018) Principles and Practice of Clinical Research, 4(1), pp. 14–20. Available at: https://journal.ppcr.org/index.php/ppcrjournal/article/view/53 (Accessed: 8 May 2024).